Sulfamethoxazole Production Cost Reports

Sulfamethoxazole production cost report provides a comprehensive analysis and know-how for setting up a Sulfamethoxazole production plant. The study covers all the requisite aspects that one needs to know for the production of Sulfamethoxazole. This includes manufacturing processes, raw material requirements, utility requirements, infrastructure requirements, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, etc.

Sulfamethoxazole is a pharmaceutical compound with a chemical formula C10H11N3O3S, and its molecular weight is 253.279 g/mol. It is an antibiotic synthesized from 3-amino-5-methylisoxazole. It is a crystalline chemical with no odor and has a density of 1.42 g/cm³, measured at 25 °C (approx.).  The compound remains stable under normal conditions. However, decomposes when heated at a high temperature. The compound, on decomposition, emits highly toxic and extremely irritating gases of nitrogen oxides and sulfoxide in the air.

It is a bitter crystalline drug with a melting point measuring approximately 167°C. Sulfamethoxazole is highly insoluble in water but can be dissolved in certain chemical solvents. It is highly soluble in compounds like acetone and is moderately soluble in ethanol. Similarly, it can also be dissolved in dimethyl sulfoxide or DMSO and dimethyl formamide. The compound is sparingly soluble in aqueous buffers as well.

It belongs to the class of bacteriostatic sulfonamide antibiotics and is majorly associated with the pharmaceutical and medical industries. It serves as an oral medication to treat bacterial infections. The compound, combined with trimethoprim (another antibiotic), is widely used to treat a variety of bacterial infections, including urinary tract infections or UTIs, middle ear infections, traveler’s diarrhea, bronchitis, and shigellosis also known as bacillary dysentery, etc. The compound works by inhibiting bacterial growth around the infected area by blocking the biosynthesis of nucleic acids and proteins essential for bacterial growth. It can help treat respiratory infections, gastrointestinal infections, and more.

The market for Sulfamethoxazole is mainly driven by its demand as an effective antibacterial drug in the pharmaceutical and medical sectors. Its application in treating a variety of bacterial infections, including urinary tract infections or UTIs, along with respiratory and intestinal infections, boosts its demand in the market. Moreover, its usage combined with trimethoprim antibiotic, fuels its demand as a bacteriostatic antibacterial drug in the medical industry.

Its demand as a medication for bacterial infection in the pharmaceutical and medical sector is one of the prominent factors that influences its procurement. Therefore, any variation in its demand as an antibiotic or antibacterial drug, along with fluctuations in its prices and distribution across borders, directly governs its procurement on a large scale.